Dataset Information

Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium.

ABSTRACT:

Background

It is not known whether modifiable lifestyle factors that predict survival after invasive breast cancer differ by subtype.

Methods

We analyzed data for 121,435 women diagnosed with breast cancer from 67 studies in the Breast Cancer Association Consortium with 16,890 deaths (8,554 breast cancer specific) over 10 years. Cox regression was used to estimate associations between risk factors and 10-year all-cause mortality and breast cancer-specific mortality overall, by estrogen receptor (ER) status, and by intrinsic-like subtype.

Results

There was no evidence of heterogeneous associations between risk factors and mortality by subtype (P _adj > 0.30). The strongest associations were between all-cause mortality and BMI ≥30 versus 18.5-25 kg/m² [HR (95% confidence interval (CI), 1.19 (1.06-1.34)]; current versus never smoking [1.37 (1.27-1.47)], high versus low physical activity [0.43 (0.21-0.86)], age ≥30 years versus <20 years at first pregnancy [0.79 (0.72-0.86)]; >0-<5 years versus ≥10 years since last full-term birth [1.31 (1.11-1.55)]; ever versus never use of oral contraceptives [0.91 (0.87-0.96)]; ever versus never use of menopausal hormone therapy, including current estrogen-progestin therapy [0.61 (0.54-0.69)]. Similar associations with breast cancer mortality were weaker; for example, 1.11 (1.02-1.21) for current versus never smoking.

Conclusions

We confirm associations between modifiable lifestyle factors and 10-year all-cause mortality. There was no strong evidence that associations differed by ER status or intrinsic-like subtype.

Impact

Given the large dataset and lack of evidence that associations between modifiable risk factors and 10-year mortality differed by subtype, these associations could be cautiously used in prognostication models to inform patient-centered care.

SUBMITTER: Morra A

PROVIDER: S-EPMC8026532 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium.

Morra Anna A Jung Audrey Y AY Behrens Sabine S Keeman Renske R Ahearn Thomas U TU Anton-Culver Hoda H Arndt Volker V Augustinsson Annelie A Auvinen Päivi K PK Beane Freeman Laura E LE Becher Heiko H Beckmann Matthias W MW Blomqvist Carl C Bojesen Stig E SE Bolla Manjeet K MK Brenner Hermann H Briceno Ignacio I Brucker Sara Y SY Camp Nicola J NJ Campa Daniele D Canzian Federico F Castelao Jose E JE Chanock Stephen J SJ Choi Ji-Yeob JY Clarke Christine L CL Couch Fergus J FJ Cox Angela A Cross Simon S SS Czene Kamila K Dörk Thilo T Dunning Alison M AM Dwek Miriam M Easton Douglas F DF Eccles Diana M DM Egan Kathleen M KM Evans D Gareth DG Fasching Peter A PA Flyger Henrik H Gago-Dominguez Manuela M Gapstur Susan M SM García-Sáenz José A JA Gaudet Mia M MM Giles Graham G GG Grip Mervi M Guénel Pascal P Haiman Christopher A CA Håkansson Niclas N Hall Per P Hamann Ute U Han Sileny N SN Hart Steven N SN Hartman Mikael M Heyworth Jane S JS Hoppe Reiner R Hopper John L JL Hunter David J DJ Ito Hidemi H Jager Agnes A Jakimovska Milena M Jakubowska Anna A Janni Wolfgang W Kaaks Rudolf R Kang Daehee D Kapoor Pooja Middha PM Kitahara Cari M CM Koutros Stella S Kraft Peter P Kristensen Vessela N VN Lacey James V JV Lambrechts Diether D Le Marchand Loic L Li Jingmei J Lindblom Annika A Lubiński Jan J Lush Michael M Mannermaa Arto A Manoochehri Mehdi M Margolin Sara S Mariapun Shivaani S Matsuo Keitaro K Mavroudis Dimitrios D Milne Roger L RL Muranen Taru A TA Newman William G WG Noh Dong-Young DY Nordestgaard Børge G BG Obi Nadia N Olshan Andrew F AF Olsson Håkan H Park-Simon Tjoung-Won TW Petridis Christos C Pharoah Paul D P PDP Plaseska-Karanfilska Dijana D Presneau Nadege N Rashid Muhammad U MU Rennert Gad G Rennert Hedy S HS Rhenius Valerie V Romero Atocha A Saloustros Emmanouil E Sawyer Elinor J EJ Schneeweiss Andreas A Schwentner Lukas L Scott Christopher C Shah Mitul M Shen Chen-Yang CY Shu Xiao-Ou XO Southey Melissa C MC Stram Daniel O DO Tamimi Rulla M RM Tapper William W Tollenaar Rob A E M RAEM Tomlinson Ian I Torres Diana D Troester Melissa A MA Truong Thérèse T Vachon Celine M CM Wang Qin Q Wang Sophia S SS Williams Justin A JA Winqvist Robert R Wolk Alicja A Wu Anna H AH Yoo Keun-Young KY Yu Jyh-Cherng JC Zheng Wei W Ziogas Argyrios A Yang Xiaohong R XR Eliassen A Heather AH Holmes Michelle D MD García-Closas Montserrat M Teo Soo Hwang SH Schmidt Marjanka K MK Chang-Claude Jenny J

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20210126 4

<h4>Background</h4>It is not known whether modifiable lifestyle factors that predict survival after invasive breast cancer differ by subtype.<h4>Methods</h4>We analyzed data for 121,435 women diagnosed with breast cancer from 67 studies in the Breast Cancer Association Consortium with 16,890 deaths (8,554 breast cancer specific) over 10 years. Cox regression was used to estimate associations between risk factors and 10-year all-cause mortality and breast cancer-specific mortality overall, by est ...[more]

PMID: 33500318

Similar Datasets

Project description:BackgroundPrevious studies have suggested that breast cancer risk factors are associated with estrogen receptor (ER) and progesterone receptor (PR) expression status of the tumors.MethodsWe pooled tumor marker and epidemiological risk factor data from 35,568 invasive breast cancer case patients from 34 studies participating in the Breast Cancer Association Consortium. Logistic regression models were used in case-case analyses to estimate associations between epidemiological risk factors and tumor subtypes, and case-control analyses to estimate associations between epidemiological risk factors and the risk of developing specific tumor subtypes in 12 population-based studies. All statistical tests were two-sided.ResultsIn case-case analyses, of the epidemiological risk factors examined, early age at menarche (≤12 years) was less frequent in case patients with PR(-) than PR(+) tumors (P = .001). Nulliparity (P = 3 × 10(-6)) and increasing age at first birth (P = 2 × 10(-9)) were less frequent in ER(-) than in ER(+) tumors. Obesity (body mass index [BMI] ≥ 30 kg/m(2)) in younger women (≤50 years) was more frequent in ER(-)/PR(-) than in ER(+)/PR(+) tumors (P = 1 × 10(-7)), whereas obesity in older women (>50 years) was less frequent in PR(-) than in PR(+) tumors (P = 6 × 10(-4)). The triple-negative (ER(-)/PR(-)/HER2(-)) or core basal phenotype (CBP; triple-negative and cytokeratins [CK]5/6(+) and/or epidermal growth factor receptor [EGFR](+)) accounted for much of the heterogeneity in parity-related variables and BMI in younger women. Case-control analyses showed that nulliparity, increasing age at first birth, and obesity in younger women showed the expected associations with the risk of ER(+) or PR(+) tumors but not triple-negative (nulliparity vs parity, odds ratio [OR] = 0.94, 95% confidence interval [CI] = 0.75 to 1.19, P = .61; 5-year increase in age at first full-term birth, OR = 0.95, 95% CI = 0.86 to 1.05, P = .34; obesity in younger women, OR = 1.36, 95% CI = 0.95 to 1.94, P = .09) or CBP tumors.ConclusionsThis study shows that reproductive factors and BMI are most clearly associated with hormone receptor-positive tumors and suggest that triple-negative or CBP tumors may have distinct etiology.

Project description:BackgroundP.I157T is a CHEK2 missense mutation associated with a modest increase in breast cancer risk. Previously, another CHEK2 mutation, the protein truncating c.1100delC has been associated with poor prognosis of breast cancer patients. Here, we have investigated patient survival and characteristics of breast tumors of germ line p.I157T carriers.MethodsWe included in the analyses 26,801 European female breast cancer patients from 15 studies participating in the Breast Cancer Association Consortium. We analyzed the association between p.I157T and the clinico-pathological breast cancer characteristics by comparing the p.I157T carrier tumors to non-carrier and c.1100delC carrier tumors. Similarly, we investigated the p.I157T associated risk of early death, breast cancer-associated death, distant metastasis, locoregional relapse and second breast cancer using Cox proportional hazards models. Additionally, we explored the p.I157T-associated genomic gene expression profile using data from breast tumors of 183 Finnish female breast cancer patients (ten p.I157T carriers) (GEO: GSE24450). Differential gene expression analysis was performed using a moderated t test. Functional enrichment was investigated using the DAVID functional annotation tool and gene set enrichment analysis (GSEA). The tumors were classified into molecular subtypes according to the St Gallen 2013 criteria and the PAM50 gene expression signature.ResultsP.I157T was not associated with increased risk of early death, breast cancer-associated death or distant metastasis relapse, and there was a significant difference in prognosis associated with the two CHEK2 mutations, p.I157T and c.1100delC. Furthermore, p.I157T was associated with lobular histological type and clinico-pathological markers of good prognosis, such as ER and PR expression, low TP53 expression and low grade. Gene expression analysis suggested luminal A to be the most common subtype for p.I157T carriers and CDH1 (cadherin 1) target genes to be significantly enriched among genes, whose expression differed between p.I157T and non-carrier tumors.ConclusionsOur analyses suggest that there are fundamental differences in breast tumors of CHEK2:p.I157T and c.1100delC carriers. The poor prognosis associated with c.1100delC cannot be generalized to other CHEK2 mutations.

Dataset Information

Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium.

Background

Methods

Results

Conclusions

Impact

Publications

Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets